Vaxart, Inc. Monovalent Norovirus Challenge Study Topline Results Conference Call September 06, 2023 at 5:00 PM EDT Listen to Webcast Supporting Materials Vaxart Monovalent Norovirus Challenge Study Data Review 1.5 MB